Insider · CIK 0001656626
AH Equity Partners Bio I, L.L.C.
Files at CAMP (Camp4 Therapeutics Corp). First filing Oct 17, 2024, latest Oct 17, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CAMP: Camp4 Therapeutics Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | Camp4 Therapeutics Corp | $8.0M 727,272 shares | +52% | +10% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Common Stockindirect: By AH Bio Fund I, L.P., as nominee | +1,398,067 | - | - | 1,398,067 | Oct 17, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | POpen-market purchase Common Stockindirect: By AH Bio Fund I, L.P., as nominee | +181,818 | $11.00 | $2.0M | 1,579,885 | Oct 17, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | POpen-market purchase Common Stockindirect: By AH Bio Fund IV, L.P., as nominee | +545,454 | $11.00 | $6.0M | 545,454 | Oct 17, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Series A Prime Preferred Stockderivativeindirect: By AH Bio Fund I, L.P., as nominee | -15,001,312 | - | - | 0 | Oct 17, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Series B Preferred Stockderivativeindirect: By AH Bio Fund I, L.P., as nominee | -679,163 | - | - | 0 | Oct 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.